Transcriptome and miRNA network analysis of familial hypercholesterolemia

International Journal of Molecular Medicine

Volumn 33, Issue 3, 2014, Pages 670-676

  Chen, Haibin ^a   Wang, Liang ^b   Jiang, Jinfa ^a  

^a TONGJI UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Familial hypercholesterolemia; Microarray analysis; Target genes

Indexed keywords

ANIMALS; ARTERIES; BIOPSY; CHOLESTEROL, LDL; CORONARY DISEASE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HEART; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; METABOLIC NETWORKS AND PATHWAYS; MICE; MICRORNAS; MYOCYTES, CARDIAC;

EID: 84893853382     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1610     Document Type: Article

References (35)

1. Jansen A, van Aalst-Cohen ES, Tanck MWT, et al: Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia. Arterioscl Thromb Vasc Biol 25: 1475-1481, 2005.
2. Rader DJ, Cohen J and Hobbs HH: Monogenic hypercholesterolemia: New insights in pathogenesis and treatment. J Clin Invest 111: 1795-1803, 2003.
3. Durrington P: Dyslipidaemia. Lancet 362: 717-731, 2003.
4. Castillo S, Tejedor D, Mozas P, et al: The apolipoprotein B R3500Q gene mutation in Spanish subjects with a clinical diagnosis of familial hypercholesterolemia. Atherosclerosis 165: 127-135, 2002.
5. Soutar AK and Naoumova RP: Mechanisms of disease: Genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4: 214-225, 2007.
6. Spies M, Dasu MR, Svrakic N, et al: Gene expression analysis in burn wounds of rats. Am J Physiol Regul Integr Comp Physiol 283: R918-R930, 2002.
7. Dušková L, Kopecková L, Jansová E, et al: An APEX-based genotyping microarray for the screening of 168 mutations asso-ciated with familial hypercholesterolemia. Atherosclerosis 216: 139-145, 2011.
8. Mosig S, Rennert K, Buttner P, et al: Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism. BMC Med Genomics 1: 60, 2008.
9. Kanehisa M and Goto S: KEGG: Kyoto Encyclopedia of Genes and genomes. Nucleic Acids Res 28: 27-30, 2000.
10. Wachi S, Yoneda K and Wu R: Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 21: 4205-4208, 2005.
11. Brivanlou AH and Darnell JE Jr: Signal transduction and the control of gene expression. Science 295: 813-818, 2002.
12. Wingender E: The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Brief Bioinform 9: 326-332, 2008.
13. Jiang C, Xuan Z, Zhao F and Zhang MQ: TRED: A transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 35: D137-D140, 2007.
14. Lu M, Zhang Q, Deng M, et al: An analysis of human microRNA and disease associations. PLoS One 3: E3420, 2008.
15. Jiang Q, Wang Y, Hao Y, et al: MiR2Disease: A manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 37: D98-D104, 2009.
16. Yang JH, Li JH, Shao P, Zhou H, Chen YQ and Qu LH: StarBase: A database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 39: D202-D209, 2011.
17. Xiao F, Zuo Z, Cai G, Kang S, Gao X and Li T: MiRecords: An integrated resource for microRNA-target interactions. Nucleic Acids Res 37: D105-D110, 2009.
18. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P and Hatzigeorgiou AG: The database of experimentally supported targets: A functional update of TarBase. Nucleic Acids Res 37: D155-D158, 2009.
19. Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3, 2004.
20. Gentleman RC, Carey VJ, Bates DM, et al: Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5: R80, 2004.
21. Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinfor-matics resources. Nat Protoc 4: 44-57, 2009.
22. Shannon P, Markiel A, Ozier O, et al: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504, 2003.
23. Draghici S, Khatri P, Tarca AL, et al: A systems biology approach for pathway level analysis. Genome Res 17: 1537-1545, 2007.
24. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ and Church GM: Systematic determination of genetic network architecture. Nat Genet 22: 281-285, 1999.
25. Draghici S, Khatri P, Martins RP, Ostermeier GC and Krawetz SA: Global functional profiling of gene expression. Genomics 81: 98-104, 2003.
26. Sun XM, Neuwirth C, Wade DP, Knight BL and Soutar AK: A mutation (T-45C) in the promoter region of the low-density-lipoprotein (LDL)-receptor gene is associated with a mild clinical phenotype in a patient with heterozygous familial hypercholesterolaemia (FH). Hum Mol Genet 4: 2125-2129, 1995.
27. Mozas P, Galetto R, Albajar M, Ros E, Pocovi M and Rodriguez-Rey JC: A mutation (-49C > T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia. J Lipid Res 43: 13-18, 2002.
28. Smith AJ, Ahmed F, Nair D, et al: A functional mutation in the LDLR promoter (-139C > G) in a patient with familial hypercholesterolemia. Eur J Hum Genet 15: 1186-1189, 2007.
29. Zhao L, Cuff CA, Moss E, et al: Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J Biol Chem 277: 35350-35356, 2002.
30. Grewal T, Boudreau M, Roy M, et al: Expression of gamma-IFN responsive genes in scavenger receptor over-expressing monocytes is associated with xanthomatosis. Atherosclerosis 138: 335-345, 1998.
31. Mosig S, Rennert K, Krause S, et al: Different functions of monocyte subsets in familial hypercholesterolemia: Potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL. FASEB J 23: 866-874, 2009.
32. Wu H, Gower RM, Wang H, et al: Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119: 2708-2717, 2009.
33. Jarvisalo MJ, Jartti L, Nanto-Salonen K, et al: Increased aortic intima-media thickness: A marker of preclinical atherosclerosis in high-risk children. Circulation 104: 2943-2947, 2001.
34. Hulthe J, Wikstrand J, Lidell A, Wendelhag I, Hansson GK and Wiklund O: Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 18: 1203-1211, 1998.
35. Binder CJ, Chang MK, Shaw PX, et al: Innate and acquired immunity in atherogenesis. Nat Med 8: 1218-1226, 2002.